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Gene expression microarrays are now established as a standard tool in biological and biochemical laboratories. Interpreting the masses of
data generated by this technology poses a number of unusual new challenges. Over the past few years a consensus has begun to emerge
concerning the most important pitfalls and the proper ways to avoid them. This review provides an overview of these ideas, beginning with
relevant aspects of experimental design and normalization, but focusing in particular on the various tools and concepts that help to interpret
microarray results. These new approaches make it much easier to extract biologically relevant and reliable hypotheses in an objective and
reasonably unbiased fashion.
© 2006 Elsevier B.V. All rights reserved.Keywords: Microarray; Gene expression; Bioinformatics; Tool; Computational biology; System biology1. Introduction
Microarrays are gaining popularity in biological laboratories
by the day. In their standard application, they measure the gene
expression status of a particular sample, by quantifying the
mRNA levels of all genes in highly parallel fashion. A single
array hybridization generates as many data as several classical
Ph.D. theses taken together. This makes the technology very
appealing as a shortcut towards data production, despite the
large financial and technical demands. To turn these data into
biological insight it is, however, necessary to interpret the
collected data. After having come to grips with the manipulation
of the large amount of collected data, the interpretation may
seem almost trivial at first: there are many possible stories that a
creative expert biologist can detect in the data, treating the
results for each gene more or less like familiar Northern blot
information. But in contrast to more traditional approaches the
main challenge is not to come up with an explanation for the
behavior of a single gene, but with one that is consistent and
well supported in the context of complementary information on
thousands of other genes.⁎ Tel.: +31 50 363 8088; fax: +31 50 363 7976.
E-mail address: r.breitling@rug.nl.
0167-4781/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbaexp.2006.06.003New ideas on how to achieve this task are developed rapidly,
new microarray tools and specialized microarray statistics are
abounding. Making an informed choice between them may
sometimes be daunting, but fortunately over the last few years a
number of comparative evaluation studies and the accumulated
experience from many thousands of microarray studies have
lead to the emergence of a set of guidelines and informal
standards that help in the process. In the following sections we
will first outline the basic conditions that need to be fulfilled
before a successful interpretation can start and describe how to
detect differentially expressed genes and how to avoid the major
pitfall associated with multiple testing. Then we proceed with a
highly selective outline of methods to organize the differential
expression information and to explore and annotate the results
to obtain a biologically coherent interpretation. We conclude
with an overview of higher-level tools that support the
integration and extension of the array results with additional
data sources. Fig. 1 summarizes the interpretation procedure.
2. Biological question and experimental design
A number of critical steps need to be taken before one can
think of interpreting a microarray result successfully. One of
these is the proper randomization during the experiment. It is
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depend on the phase of the moon. For microarray analysis
this is almost true. Gene expression responds very sensitively
to changes in environmental conditions, even if they appear
very minor. Consistent and statistically significant fluctuations
in expression pattern have been reported in wild type yeast
cultures incubated under constant standard growth conditions
[1]. Even for genetically homogeneous inbred mouse strains
reared under highly-controlled, pathogen-free laboratory
conditions and matched for age and sex reproducible and
statistically significant inter-individual variation in gene
expression has been reported [2]. It was necessary to control
many additional variables like social status, stress, and food
intake to reduce this biological variation to a minimum. Even
then, individual mice showed significant differential expres-
sion of some genes. Similar effects have been reported for
Arabidopsis, where even simply touching the plants can
lead to significant changes in gene expression [3]. Therefore,
it is of utmost importance for the generation of interpretable
microarray results to randomize or control all possible
confounding factors. If two conditions are to be compared,
then it is not sufficient to, for example, obtain the material at
the same temperature and in the same medium, but it should
preferably be grown in the same incubator, in random spatial
arrangement and harvested in random order by the same
person. The exact factors to be randomized will depend on
the particular experimental set-up, but in any case it will be
crucial to realize that the most unexpected subtle systematic
difference between the sampling (and measurement) condi-
tions will lead to biased results—making the data all but
impossible to interpret.Fig. 1. Critical steps in microarray interpretation. The major steps of the usual interpre
are briefly indicated at the right. See main text for detailed discussion and the descrTo be able to interpret microarray data, it is also necessary
to have a sufficient number of replicate measurements. Such
replication is necessary to assess which results will have real
predictive value, i.e. are expected to be verified in a new
experiment, and which observations are only spurious.
Statistical approaches allow one to assess the number of
replicates necessary to reliably detect an expected effect of a
certain size. For most applications, where financial and
logistic constraints limit the number of hybridizations, this is
merely an academic exercise. The more replicates the better.
A real choice occurs when the type of replicates is chosen.
Here it is important to realize that arrays show surprisingly
little technical (labeling- or hybridization-specific) variation.
Most of the observed expression variation is due to biological
variability (day-to-day or interindividual variation; [4–7]). It
is, therefore, most efficient and informative to perform as
many biological replicates as possible. Rather than hybridiz-
ing a specific sample twice, isolate the same type of mRNA
from a completely independent new sample. This will help to
detect those expression changes that are reproducible and
relevant. Detailed reviews of experimental design considera-
tions, in particular for more complex experiments such as
large time courses or multifactorial comparisons, are available
in [8,9].
3. Hybridization
The choice of array platform and other technical details of
the actual microarray experiment (sample preparation, hybridi-
zation, image processing) of course also influence the down-
stream analysis, but these will not be discussed in this paper. Fortation process are outlined. Major pitfalls and some related analytical approaches
iption of additional relevant tools and methods.
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[6,10–13].
4. Normalization
Before analysis, data usually need to be normalized, to
remove obvious systematic differences between samples. For
example, in a standard array experiment, the amount of labeled
cRNA in all samples should be the same, so normalization could
involve some scaling of the expression values, so that the
average signal is identical for all arrays. Many procedures have
been suggested for systematic normalization, but it seems that
the simplest strategies often perform best. For two-color arrays,
normalization can, for example, be performed by a simple
quantile normalization [14], which makes the distribution of
intensities identical on all arrays and colors. This extends the
original (and still widely used) idea that one could normalize by
making the mean and variance identical for all samples and has
been reported to have superior performance [14]. This can then
be followed by a variance stabilizing normalization [15–17],
which handles the problem caused by wide fluctuations of log-
ratios for genes that are expressed at the detection limit. A
simple alternative – that often works surprisingly well – is just
to forgo background subtraction (which in any case just tends to
introduce additional noise). This procedure has a similar effect
as a started-log transformation, which is the most simple form of
variance stabilization [18]. For one-color genechip arrays, it
seems most important not to use the standard normalization
provided by the MAS5/GCOS software of Affymetrix. This
normalization has been shown to perform consistently poorly in
various comparative evaluations [19–23], so use of MAS5/
GCOS should be restricted to the lowest level analysis, such as
the initial image processing. Of the alternative normalization
techniques, RMA [19] seems to show the most consistent good
performance, with its modification GCRMA [24] and the dChip
method [25] being close second. The RMA method includes
quantile normalization and variance stabilization components
and doesn't use the “information” from mismatch probes, so it
corresponds quite closely to the procedure suggested for two-
color arrays. Both methods do not do background subtraction
and thus do not have to deal with negative expression values.
Avoiding arbitrary filtering, e.g. based on above-background
expression or spot quality, is usually recommended.
5. Differentially expressed genes
Detecting genes that show reproducible differences in
mRNA abundance between sample classes is probably the
most basic and important step of microarray analysis. A huge
variety of methods have been used for this task, and when
sufficient replicates are available all of them work. What is not
sufficient is a simple calculation of fold-change and arbitrary
thresholding—unless the data are not replicated at all (which is
in itself very problematic). This will fail to discriminate between
changes that are spurious and those that are reproducible. Also
the choice of a fold-change threshold is very subjective and is so
much dependent on the experiment and technological variablesthat any (or no) choice can be justified. When the number of
replicates is very small, methods based on the t-test, including
the popular SAM [26], have difficulties and can be replaced by
equally simple approaches that are designed for small numbers
of replicates, such as Rank Products [27,28]. Rank Products
have the additional benefit that they by design are able to detect
rare but interesting expression changes (with statistical
significance), that would be missed by many other approaches.
Alternatively, the Empirical Bayes modification of the t-test can
be used with good success [29,30], as can be other Bayesian
approaches [31,32].
For experiments that compare more than two conditions the
t-test can be replaced by an Analysis of Variance (ANOVA)
[33]. This requires some more statistical expertise, but the
necessary tools are available with extensive documentation,
e.g., in the BioConductor package of the R statistical language
[34].
In any case it is highly recommended to use “standard”
methods, instead of reinventing the wheel. It is very challenging
to demonstrate that a new method really outperforms the
available ones. This needs to be shown quantitatively for a large
number of datasets. Any performance differences will be subtle
and difficult to show robustly, and the danger of “optimizing”
(over-fitting) an analysis technique for a particular dataset is
large.
The result of all the statistical tests is a p-value for each gene,
which basically describes how likely it would be to observe a
particular differential expression by chance. This concept is not
just a formal statistical idea, but also a straightforward estimate
of the ability to predict the outcome of future experiments. This
estimate is based on the observed variability and effect size in
replicated independent measurements. Therefore replicate
measurements are essential in any microarray experiment.
6. Significance and multiple testing
Multiple testing is the most dangerous pitfall of the
microarray interpretation process. It comes in many forms,
and is sometimes so cleverly disguised that it is hard to
recognize the problem. In the classical case, it refers to the
situation that one tests the differential expression of thousands
of genes in parallel. The classically calculated statistical
significance (p-values) are designed for single tests, they tell
the user how likely a certain effect is to be observed by chance.
For example, a p-value of 0.05 means that such a strong effect
(e.g., differential expression) would be observed by chance in
one of 20 tests. Usually that's considered significant, but in the
multiple testing situation of microarrays, it rarely is. Among
10,000 genes tested in parallel, it is expected that about 500
genes would reach such a p-value just by chance, even if they
are not differentially expressed at all. These genes would be
likely to be false positives, basically artifacts of the statistical
analysis procedure.
One way to overcome this problem is to use stricter
thresholds. In the above example, a p-value smaller than
0.05/10,000=5⁎10E-6 would be expected only once in 20
experiments, just as strict as the original single-test
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however, quite strict and is currently rarely applied in
microarray interpretation. In its place, the False Discovery
Rate (FDR; [36]) is most widely used. This clever and
intuitive method controls the expected number of false-
positive results in the list of results, rather than the number
of experiments in which any mistake is made. This leads to
a more lenient threshold that also flexibly depends on the
observed data. The FDR is so simple that one can estimate it
manually for a given result, and that can be highly
instructive when reading the literature. For example, if a
paper reports that 25,000 genes were analyzed, 500 of which
were differentially expressed at a p-value of 0.01, one can
easily calculate that N=25,000×0.01=250 genes are
expected to show such a change by chance, leading to an
FDR of 50%, much larger than would ever be acceptable in
a conventional publication. For microarray publications,
FDRs between 1% and 10% are considered reasonably
strict. More lenient thresholds lead to results that are difficult
to distinguish from random gene lists. Notice that there are
other variants of multiple testing, not just the large number
of genes causes problems, but sometimes tests are also
performed multiple times for various subdivisions of the
data, for particular versions of the normalization or for
different test statistics. Each of these has the potential to lead
to the discovery of spurious false positives if it is not treated
carefully.
Any statistical significance test has the potential to reject true
positive results, i.e. it will miss genes that are in fact
differentially expressed. To control this problem, it is useful
to complement the FDR estimates with information on the
expected false negative rate [37] or ‘miss rate’ [38].
The FDR is a property of an entire list of genes, it gives an
estimate of how many of the genes that are reported as
differentially expressed are likely to be false positives. Of
course within this list of genes, those with the smaller p-values
will still be the most significant candidates, so the classical p-
values are still relevant (or one may want to use their FDR-
related equivalent, the gene-specific q-values [39]). Also,
among the genes that are statistically significant at a certain
FDR level, some may be unlikely candidates, for instance
because their overall fold-changes are very low. Additional
limitation of the reported list based on such criteria may be
helpful for display purposes.
As long as multiple testing is properly addressed, all choices
at the other steps of the interpretation process have only
relatively minor consequences. Ignoring the multiple testing
problem has, on the other hand, resulted in the publication of
elaborate biological stories that were based on about 100% false
positive expression changes. That it is possible to generate such
stories is a testament to the creativity and expert knowledge of
the analyst—but it should also serve as a warning for anybody
trying to interpret a microarray result. It is very easy to see the
patterns one wants to see and assign meaning to observations
that are purely the result of random fluctuations. Because
microarrays generate so many data, they make it particularly
easy to come up with seemingly plausible, but irreproducible,interpretations [40]. The next section discusses some
approaches that try to minimize these dangers.
7. Data mining: making sense of differential expression
To interpret microarrays in a systematic way, some
“dimensionality reduction” is required. This means that the
factors or phenomena that dominate the observed data need to
be extracted and emphasized. There are two principal ways of
achieving this, both with their advantages and disadvantages.
The first one, cluster analysis, is exclusively data-driven, the
second one, annotation analysis, is knowledge-driven. The first
one may tend to miss subtle patterns that are immediately
obvious if previous biological knowledge is considered, the
second one may be overly restrictive (or even biased) by its
almost exclusive focus on genes and processes that have been
annotated already. We will discuss both approaches in turn.
Clustering and its relatives (like PCA) are almost emblematic
for microarray analysis. A gene expression paper is almost
considered incomplete if it doesn't contain a colored heatmap
sorted by hierarchical clustering as first introduced in a classical
paper by Eisen et al. [41]. These techniques have been
traditionally used for dimensionality reduction, i.e. to make
the huge amounts of complex information contained in a
microarray more digestible for the interpreter. They are
extremely useful for visualization purposes and quality control.
For example, a heatmap sorted by hierarchical clustering will
give a quick visual impression of which groups of samples are
most similar and highlight samples that stand out from their
group (and thus may have technical problems). It will also show
if there are large groups of genes that show consistent correlated
behavior across samples. However, because they focus on the
large-scale patterns distinguishing samples, a limited number of
dimensions, they may discard too much of the more subtle
variation that may contain most of the biological signal. On the
other hand, in some situations they may focus too much on
stochastic fluctuations in the data. If one is comparing two
conditions in replicated measurements, clustering cannot
produce more information than is already available from the
differential expression analysis. Any clusters beyond the simple
up-down and down-up patterns will be based on the random
fluctuations within conditions. Where the data are suitable for
clustering approaches, i.e. where a sufficiently large number of
conditions are compared, it may be interesting to consider more
flexible approaches than the most popular hierarchical cluster-
ing and PCA. For example, k-means clustering may perform
consistently better than hierarchical clustering [42,43] and self-
organizing maps can also be very powerful if applied with
sufficient statistical expertise [44]. Other approaches, like
Linear Factor Models (LFM, [45]) allow each gene to be a
member of multiple clusters and due to its biology-based
underlying assumptions generates results that are much more
accurate reflections of the physiological pattern than is possible
with PCA. Using a biologically plausible model the LFM
approach will basically detect the most suitable small number of
“biological processes” (e.g. activated regulatory cascades) that
are necessary to give an accurate representation of the observed
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similar concepts and is particularly suited for the (meta-)
analysis of very large expression datasets. If the dataset is
comprehensive enough it can also be used to determine
transcriptional regulatory modules, as has been shown for a
1000-array dataset from yeast [47]. But, while it is useful to
consider clustering approaches that go beyond the traditional,
simplicity of the analysis can also be beneficial: for the related
task of classification Dudoit et al. [48] have demonstrated that
the simplest methods show remarkably good performance.
If clusters are sufficiently coherent (i.e. specifically regulated
by a common set of transcription factors), they can be used to
mine for the responsible transcription factor modules in their 3′
untranslated regions [49]. One tool that is useful for identifying
overrepresented motifs is MEME [50]. The false positive rate of
such methods is very high and care has to be taken to validate
the discovered motifs. Even if no additional experimentation is
immediately possible, examining the results for low complexity
regions, which may correspond to compositional biases rather
than transcription factor binding sites, is an important first step.
The next step, with or without clustering, is the annotation of
the results. This can be done manually, based on expert
knowledge and careful literature study on the dozens or
hundreds of genes that are detected. This step is most imperiled
by interpreter bias, a.k.a. expert knowledge and previous
expectations. To overcome this problem, automated methods
have been devised to perform this task. There is a very large
number of tools available [51] that differ in the details of their
implementation (e.g., which gene identifiers can be processed,
how the results are displayed, how the annotation is kept up-to-
date), but they all use the same basic principle. Given a list of
genes and the annotation of the genome they calculate if a
certain functional category is statistically overrepresented in the
selected group of genes, compared to the rest of the genome.
The most surprisingly enriched gene groups usually yield
valuable clues with respect to the affected biological processes
in a particular experiment. Because the enrichment is calculated
on statistical principles and summarized in a regular p-value,
the results are more objective and easier to compare than those
of a manual analysis (which may often lead to similar
conclusions). The most popular software tools used for this
purpose are Onto-Express [52], GOstat [53], GoMiner [54] and
EASE [55], but many others are available and may be just as
useful or even better for particular situations (see review by
Khatri and Draghici, [51] for a detailed comparison of a large
part of them).
The annotation that is most often used for this type of
analysis is the Gene Ontology [56], a controlled vocabulary that
uses standardized and centrally curated terms to describe the
biological function of genes and their products. Such a well-
defined vocabulary is on the one hand useful, because it makes
results more comparable, but on the other hand it can be overly
restrictive and can miss important information that would be
provided by more flexible annotation systems. This is a major
limitation of many of the tools discussed above. Using custom-
made annotations, such as groups of genes that one knows to be
of interest, based on literature research or previous experimentsof various kinds, can be a major advantage. It does, however,
often require at least a moderate amount of bioinformatics
support.
Another limitation of the gene-enrichment detection methods
discussed, is their focus on a pre-defined, fixed group of
differentially expressed genes. Of course, even if the selection
of this group is based on solid statistical criteria, it is influenced
by arbitrary decisions: which p-value threshold should be used?
How many false positive results is one willing to accept? But
also, and this is sometimes neglected, how many false negative
results follow from this decision? One implementation of the
gene-enrichment detection algorithm, called iterative Group
Analysis [57], overcomes this problem by using flexible
thresholds, so that for each functional group of genes, the
most appropriate cutoff point is defined automatically. This can
lead to dramatic improvements for the detection of some
functional classes, in particular those that show concerted and
very interesting changes in expression, but only limited absolute
changes. iGA can also handle a wide range of custom-defined
gene annotations.
A global analysis of gene lists that determines the overall
enrichment of genes is only a first step in the annotation process.
The next level of analysis requires to make connections between
genes. Are the detected enriched processes related? How do
genes and their functions link up to a larger picture? Again this
placement of the isolated findings in their physiological context
can be done manually, with full creative freedom, but it can also
be supported and guided by a number of computational tools
that help to visualize the relationships between genes based on
complementary knowledge.
A successful tool of this type is the popular MAPMAN
software [58,59], which is mainly used in the plant science
community. It allows the projection of gene expression data on
network pictures, such as metabolic maps and signaling
pathways, and can serve to rapidly highlight areas in cellular
physiology that are most strongly affected by differential
expression. It also can be used to create aesthetically pleasing,
publication-quality figures of these network pictures.
Cytoscape [60] is another program for integrating gene
interaction information and gene expression data in a unified
framework for visualization and exploration. It allows the
display of large gene networks, which place the individual
expression changes in their biological context. The program has
been extended by a wide variety of specialized modules, both
by the original authors and other groups. An example is the
ActiveModules plug-in, which can be used to detect connected
subnetworks within a gene network whose members show
significant coordinated changes in mRNA-expression over a
variety of experimental perturbations [61]. This extensible
architecture of the software and its excellent graph visualization
properties make it very versatile for integrating data, including
many types of molecular interaction data, and working in a
systems biology framework.
Graph-based iterative group analysis (GiGA; [62]) is another
higher-level interpretation method. It extends the scope of iGA
(see above) to detect statistically significant areas (subgraphs) in
a gene network, which respond most remarkably to a certain
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regulation data (including transcription factor binding sites),
metabolic connectivity, physical interactions, literature co-
citations or other information that can serve to link genes
conceptually [63]. Focusing on those areas in the conceptual
network that are most strongly affected by the treatment of
interest can narrow down the search space sufficiently to arrive
at a consistent and convincing interpretation rapidly.
A related tool is Pathway-Express, which is restricted to a
single list of potential genes of interest [64]. Its aim is to identify
and display those cellular pathways involving genes of the list
that are most “interesting” based on probabilistic criteria.
GeneMAPP and the related MAPPFinder gene ontology tool
also fall into this category of interpretation tools [65,66].
The tools described will help to find biological processes that
seem to be responding to certain treatments or conditions. The
results must, however, be taken with a grain of salt. It is not
uncommon to detect, e.g., ribosomal proteins as a responsive
group. Does that mean that protein synthesis is noticeably
changed? Possibly, although protein and mRNA levels correlate
only weakly for ribosomal proteins [67]. But will that be part of
a specific adaptive program? That is even less likely. It seems
that certain groups of genes, and ribosomal ones in particular,
respond very sensitively to any fluctuation in the environmental
conditions, but probably without major specific consequences.
The fact that ribosomal expression changes have been reported
for dozens of experiments, ranging from yeast diauxic shift [68]
to metamorphosis of ants [69], makes such observations too
unspecific for further interpretation, even if they have a general
biological relevance (energy expenditure for protein synthesis
should, after all, be finely regulated). This broader context of
expression variation needs to be kept in mind when analyzing a
particular experiment. It also may be necessary to consider the
possibility that most expression variations may be random and
of no biological significance, no matter how statistically
significant they may be. They may be due to spontaneous
mutations of regulatory sites that become fixed in the genome
by chance, but may be inconsequential and entirely unrelated to
the adaptive response to a particular physiological situation. On
the other hand, it has been shown for C. elegans that
intraspecific evolution of transcriptional variation is in many
cases subject to intense stabilizing selection [70]. This
observation might indicate that a considerable fraction of
expression changes will have adaptive consequences and is
therefore biologically relevant.
Comparing gene expression responses in various conditions,
e.g. the response of mutant and wild type cells to a common
stress drug treatment, is also often of interest. Here one can't
directly compare the gene expression levels (wild type and
mutant will differ even without treatment), but will instead
focus on the relative differences in response compared to the
corresponding unchallenged state. The statistically comprehen-
sive way of analysis such a case is analysis of variance
(ANOVA; [33]), but this requires statistical expertise and the
results are not always straightforward to visualize and interpret.
The more common method is to plot Venn diagrams that show
the overlap and difference between the sets of differentiallyexpressed genes. The disadvantage is that the message (and
interpretation) of Venn diagrams can be dramatically different if
different thresholds are used for defining the set of differentially
expressed genes. VectorAnalysis [71] is a tool that offers the
intuitive visualization and grouping of genes into various
response classes, as in Venn diagrams, but at the same time
provides a statistical foundation of these assignments and is
independent of arbitrary expression thresholds.
8. Conceptual integration
Several tools help to move beyond the interpretation of
microarray results in isolation. Two particularly comprehensive
examples are the commercial bioinformatics efforts of Geno-
matix and Ingenuity. The former integrates expression data with
up-to-date genome information, offers powerful tools for
extracting potential regulatory motifs (transcription factor
modules; [72]) and also gives targeted access to the literature
associated with a particular set of genes, using statistical
methods to detect potential links between publications and
genes [73]. The hierarchical combination of the components of
this toolbox can highlight relevant cross-connections that may
escape a more compartmentalized analysis. At the same time
they offer so many potential leads that wise restraint is
necessary before making hard conclusions about the meaning
and significance of a particular observation—the statistics
implemented in the platform are only a first step to help with
this, but careful consideration of hidden multiple testing “traps”
is required. How many similarly “significant” results were
discarded, because they didn't add up to an exciting biological
story? The Ingenuity pathway analyzer uses similar basic
principles as the GiGA approach described above [62], but
complements it with extensively curated gene networks and
tools to add and edit customized networks (www.ingenuity.
com). The user-interface also provides easy access to the
available literature, both relating to genes and to the connections
between them. Both software packages are web-based for easy
access and offer free trial accounts and special licensing
agreements for academic scientists. Separate free software for
many of the individual steps of the analysis offered by these
commercial efforts is available, but they derive their main
power from the integration of diverse information in a unified
and highly accessible interface.
Of course, data integration and the generation of complex,
informative hypotheses at the systems level is not an aim in
itself. Only if the hypotheses are sufficiently convincing and
reliable to be tested in the biological laboratory has the
interpretation process been really successful. In fact, restricting
the reported results of a microarray study to those aspects that
one is willing to pursue by direct experimental testing, might
yield an even greater improvement in interpretation quality than
refinements of subtle statistical aspects.
Another important aspect of microarray interpretation is its
open nature. The interpretation is not finished when the original
experimenter has made her conclusions, but the data can be
reanalyzed by other people. Comparing one's own results to
those of other people can lead to important refinements and
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C. elegans researcher may want to find the place of their most
responsive genes on the global gene expression map of Kim et
al. [74], which it possible via the website of the authors. To
make such comparative analysis possible, it is essential that the
data are publicly available. The current major repositories
(Gene Expression Omnibus [75], ArrayExpress [76], Stanford
Microarray Database [77]) are still very difficult to exploit
spontaneously and in a global manner, but the user interfaces are
continuously developing and already give access to tens of
thousands of experiments. Every researcher should consider to
make their own data available in this form for future
interpretation.
9. Conclusion
Microarray interpretation is as much an art as it is a
science. There are, however, a number of standards that
have emerged over the past years that help to make the
interpretation process more objective and reliable. The most
important advance is the availability of tools that reduce the
human factor in the initial annotation of the experimental
results. This does not mean that expert analysts and
interpreters will be replaced by the computer, but opens
new opportunities to produce creative yet well-founded
interpretations to hold up against the mounting onslaught of
new and exciting microarray datasets.
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